TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
LXEO

Lexeo Therapeutics, Inc.

Healthcare · Biotechnology · —

3.30$ -2.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Lexeo Therapeutics, Inc. (LXEO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 255 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LXEO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
55 140 213 192 174 147 126 176 144 269 250 255
39 124 198 177 159 126 105 140 128 188 201 218
35 121 195 175 157 35 29 35 41 63 72 93
35 121 195 175 157 122 100 133 41 182 72 212
218 26 30 27 35 30 38 38 23 22 19 20
23 17 22 19 27 23 31 32 17 17 14 16
6.7 2.6 2.6 2.7 2.7 2.7 2.6 2.7 2.7 2.7 2.7 2.7
2.7 3.8 4.3 5.8 8.4 6.4 12 20 4.7 4.9 3.3 4.2
-163 114 183 165 139 117 88 138 121 247 231 235
-168 -182 -204 -225 -254 -280 -313 -339 -359 -380 -400 -426
25 27 28 33 33 33 33 44 61 76 81 86

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?